MDxHealth SA (MDXH)
2.50
-0.06
(-2.34%)
USD |
NASDAQ |
Jun 25, 16:00
MDxHealth Revenue (Quarterly): 19.83M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.83M |
| December 31, 2023 | 19.40M |
| September 30, 2023 | 19.35M |
| June 30, 2023 | 16.74M |
| March 31, 2023 | 14.70M |
| December 31, 2022 | 12.89M |
| Date | Value |
|---|---|
| September 30, 2022 | 11.15M |
| June 30, 2022 | 6.903M |
| March 31, 2022 | 6.106M |
| December 31, 2021 | 6.013M |
| September 30, 2021 | 5.495M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.495M
Minimum
Sep 2021
19.83M
Maximum
Mar 2024
12.60M
Average
12.89M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
| Galapagos NV | 67.81M |
| UCB SA | -- |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | 1.326M |
| Celyad Oncology SA | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.511M |
| Total Expenses (Quarterly) | 26.44M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | 90.15M |
| Gross Profit Margin (Quarterly) | 60.82% |
| Profit Margin (Quarterly) | -42.91% |
| Earnings Yield | -59.72% |
| Normalized Earnings Yield | -59.72 |